TOThania Ordaz-Robles

Thania Ordaz-Robles

*This is an algorithmically generated author record based on publicly available information.

Thania Ordaz-Robles has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Osteogenesis Imperfecta Caused by Ultra-Rare Variants in IFITM5: New Cases and Molecular Studies on Missense Variants

    by Thania Ordaz-Robles, Matthew Tiranardi, José Gilberto Ríos-Ruíz, Ghalib Bardai, Frank Rauch, Pierre Moffatt

    Variants in IFITM5 are a unique cause of osteogenesis imperfecta (OI). The recurrent c.-14C>T leads to classical OI type V, whereas missense variants are considerably rarer and associated with a distinct phenotype. Here we present 3 Mexican boys with IFITM5 missense variants and investigated their cellular and molecular consequences in vitro. Individual 1 (p.Ser40Trp) had a history of 30 fractures, primarily involving both femurs, leading to bone deformities and short stature (height z-score -3.1). Individual 2 (p.Ser40Leu) had bilateral lower extremity deformities at birth and sustained 15 fractures postnatally. Individual 3 (p.Asn48Ser) experienced 6 fractures, all involving the left femur. None exhibited the hallmark features of OI type V, including hyperplastic callus formation or interosseous membrane calcification. Transient transfection in MC3T3-E1 preosteoblasts showed that all 3 IFITM5 variants were aberrantly retained in the endoplasmic reticulum-Golgi compartment, although total protein levels remained normal. In a MEF2-based luciferase assay in MLO-A5 osteocytic cells, the variants failed to elicit a signaling response and exerted dominant negative effects on wild type IFITM5 when co-expressed. Consistently, plasma membrane localization of the wild type protein was reduced in the presence of the mutants. Additional variants identified in ClinVar and gnomAD (p.Ser40Pro, p.Asn48Asp, and p.Asn48His) showed similar intracellular retention and loss of activity. Biochemical analyses indicated loss of palmitoylation of the adjacent cysteine residues. These findings expand the clinical spectrum of IFITM5 missense variants and demonstrate a dominant negative disease mechanism distinct from the classical IFITM5 c.-14C>T variant.

  • Open Access

    A phenotypic paradigm for cerebral palsy genetics

    by Adam S. Arterbery, Michael A. Gargano, Anita Bagley, Jagadish Chandrabose Sundaramurthi, Lauren Rekerle, Thania Ordaz-Robles, Daniel Danis, Adam S.L. Graefe, Ana L. Arenas-Díaz, Jeremy P. Bauer, et al.

  • Open Access

    A Phenotypic Paradigm for Cerebral Palsy Genetics

    by Adam S Arterbery, Michael A Gargano, Anita M Bagley, Jagadish Chandrabose Sundaramurthi, Lauren Rekerle, Thania Ordaz-Robles, Daniel Danis, Adam Sl Graefe, Ana L Arenas-Díaz, Jeremy P Bauer, et al.

    Disease-causing genetic variants can be found in a subset of individuals with cerebral palsy (CP), with variants deemed causal of CP having been published for at least 515 genes. We develop a statistical approach that treats CP as a phenotypic feature for which some genetic disorders confer an increased risk. Based on comprehensive literature curation we show that the null hypothesis of no CP association can be rejected for only 89 of the 515 genes. We applied these findings to the analysis of a cohort of 460 children diagnosed with CP in the Shriner Children's network. We identified pathogenic or likely pathogenic (P/LP) variants in 60 genes in 15.8% of the children. Only 16 of the 60 genes had significant evidence for CP association in our literature analysis. Our results suggest that a stratified approach to attributing causality to genetic variants in CP could support precision genomic medicine for affected individuals.

  • FLNA Variants Related to Melnick‐Needles Syndrome: Two Mexican Case Reports and a Comprehensive Variant Review

    by Thania Ordaz‐Robles, Jessica Vanesa Sánchez‐Aguilar, Carlos Alfonso Guzmán‐Martín, Sergio Saldaña‐Pimentel, Ilan Vinitzky Brener, Fernando Ramírez‐Jiménez, María Hortensia Valdez‐De la Torre, Ghalib Bardai, Frank Rauch

    Melnick‐Needles Syndrome (MNS; OMIM #309350) is a rare X‐linked dominant osteochondrodysplasia caused by FLNA gain‐of‐function variants. It is characterized by short stature, facial dysmorphism, skeletal anomalies, and systemic complications. FLNA encodes Filamin A, a cytoskeletal protein with over 90 binding partners. Variants in FLNA cause a broad spectrum of disorders, among which MNS represents one of the most severe phenotypes. Despite increasing research on MNS, many aspects of its genetic and phenotypic spectrum remain unknown. In this work, we presented two Mexican cases with a diagnosis of MNS with different FLNA missense variants p.(Leu1193Pro) and p.(Ser1199Leu). In addition, we performed a comprehensive review of the literature about FLNA variants related to MNS. This study reinforced the genetic and phenotypic complexity of MNS, emphasizing the critical role of exon 22 variants in the pathogenesis of the disease.